Here we review published data from 24-h time-averaged HR monitoring in healthy individuals and subjects with type 2 diabetes mellitus (T2DM) treated with either short-acting GLP-1 RAs, lixisenatide or exenatide, or long-acting GLP-1 RAs, exenatide LAR, liraglutide, albiglutide, or dulaglutide (N = 1112
the formula is caffeine-free and won't disrupt energy levels or recovery
Free Radical Biology & Medicine, 49(11), 16031616
GLP-1 therapy may help by reducing the biological drive to overeat
In this article, we explore the science behind GLP-1 and show how diet, lifestyle, and microbiome insights can help you naturally support this critical hormone